FDA Signals Fresh Scrutiny Of Opioid Painkillers
The U.S. Food and Drug Administration said Wednesday it would devote a two-day hearing to the use of opioids in chronic pain, a move that could affect some of the nation's...To view the full article, register now.
Already a subscriber? Click here to view full article